Depo-Provera Lawsuit Lawyer: Meningioma Claims

Lawsuits allege that the maker of Depo-Provera, an injectable birth control, failed to warn that long-term use may increase the risk of meningioma, a usually noncancerous tumor of the brain’s lining.

• Meningioma
• Effects of tumor treatment, such as surgery

People who received Depo-Provera injections and were later diagnosed with a meningioma may qualify. Every case depends on medical records and timing.

Federal cases are consolidated as In re: Depo-Provera Products Liability Litigation, MDL No. 3140, before Judge M. Casey Rodgers in the U.S. District Court for the Northern District of Florida. The panel centralized the cases on February 7, 2025. Court orders now describe a settlement program: Case Management Order No. 18 (September 15, 2026) set up an administrative docket where eligible claimants already registered in the program must file complaints by November 30, 2026. Settlement terms are confidential, and the defendants maintain the drug is safe and effective. Cases outside the program continue in the MDL. If you think you qualify, don’t wait. Source: U.S. District Court, N.D. Fla..

• Medical records showing the diagnosis
• Pharmacy or purchase records showing use of the product
• A timeline of when you used the product and when symptoms began

Kentucky product injury claims generally must be filed within one year of when the injury was discovered or reasonably should have been discovered. Rules vary by state and case, and court orders in these cases can set their own dates. Estimate dates with our statute of limitations calculator and talk with a lawyer.